[Comparison of efficacy of pegylated interferon alfa-2a or interferon alfa-2b combination therapy with nucleus(t)ide analogues in HBeAg positive chronic hepatitis B patients]

Zhonghua Gan Zang Bing Za Zhi. 2011 Oct;19(10):785-6.
[Article in Chinese]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Hepatitis B e Antigens
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / immunology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use*
  • Male
  • Nucleotides / administration & dosage
  • Nucleotides / therapeutic use*
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Treatment Outcome
  • Young Adult

Substances

  • Antiviral Agents
  • Hepatitis B e Antigens
  • Interferon alpha-2
  • Interferon-alpha
  • Nucleotides
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a